Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Exchange Rate Effect (2016 - 2025)

KalVista Pharmaceuticals' Exchange Rate Effect history spans 8 years, with the latest figure at $3.4 million for Q2 2025.

  • On a quarterly basis, Exchange Rate Effect rose 4645.95% to $3.4 million in Q2 2025 year-over-year; TTM through Apr 2025 was $3.8 million, a 414.43% increase, with the full-year FY2025 number at $2.6 million, up 317.56% from a year prior.
  • Exchange Rate Effect hit $3.4 million in Q2 2025 for KalVista Pharmaceuticals, up from $407000.0 in the prior quarter.
  • Over the last five years, Exchange Rate Effect for KALV hit a ceiling of $3.4 million in Q2 2025 and a floor of -$621000.0 in Q1 2024.
  • Historically, Exchange Rate Effect has averaged $382142.9 across 3 years, with a median of $84000.0 in 2023.
  • Biggest five-year swings in Exchange Rate Effect: surged 39.29% in 2024 and later skyrocketed 4645.95% in 2025.
  • Tracing KALV's Exchange Rate Effect over 3 years: stood at -$602000.0 in 2023, then soared by 167.61% to $407000.0 in 2024, then skyrocketed by 726.54% to $3.4 million in 2025.
  • Business Quant data shows Exchange Rate Effect for KALV at $3.4 million in Q2 2025, $407000.0 in Q4 2024, and $117000.0 in Q3 2024.